[The management of retention is acquired neurogenic bladder].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D004558:Electric Stimulation; D006801:Humans; D010277:Parasympathomimetics / Q000627:therapeutic use; D001750:Urinary Bladder, Neurogenic / Q000175:diagnosis* / Q000628:therapy; D014563:Urodynamics; D014567:Urography
D000317:Adrenergic alpha-Antagonists; D010277:Parasympathomimetics
Conduite à tenir devant une rétention dans une neurovessie acquise.